Publications by authors named "Wouter P C Boon"

Claim this Profile
E
Exploring scenarios for implementing fast quantitative MRI.
Susan V van Hees, Martin B Schilder, Alexandra Keyser, Alessandro Sbrizzi, Jordi P D Kleinloog, Wouter P C Boon

Eur J Radiol Open· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
AI-Assisted Decision-Making in Long-Term Care: Qualitative Study on Prerequisites for Responsible Innovation.
Dirk R M Lukkien, Nathalie E Stolwijk, Sima Ipakchian Askari, Bob M Hofstede, Henk Herman Nap, Wouter P C Boon

JMIR Nurs· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Making Co-Design More Responsible: Case Study on the Development of an AI-Based Decision Support System in Dementia Care.
Dirk R M Lukkien, Sima Ipakchian Askari, Nathalie E Stolwijk, Bob M Hofstede, Henk Herman Nap, Wouter P C Boon

JMIR Hum Factors· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preferred Islet Delivery Device Characteristics and Implantation Strategies of Patients With Type 1 Diabetes.
Maarten C Tol, Denise F A de Bont, Wouter P C Boon, Eelco J P de Koning, Aart A van Apeldoorn

Transpl Int· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring the feasibility of introducing triple artemisinin-based combination therapy in the malaria treatment policy in Vietnam.
Van Anh Thi Cao, Thieu Quang Nguyen, Duong Le Quyen, Wouter P C Boon, Ellen H M Moors

Malar J· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Strategies for deploying triple artemisinin-based combination therapy in the Greater Mekong Subregion.
Freek de Haan, Chanaki Amaratunga, Van Anh Cao Thi, Long Heng Orng, Manithong Vonglokham, Wouter P C Boon

Malar J· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of anti-malarial markets on artemisinin resistance: perspectives from Burkina Faso.
Rosemonde M Guissou, Chanaki Amaratunga, Freek de Haan, Fatoumata Tou, Phaik Yeong Cheah, Wouter P C Boon

Malar J· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Translatability of preclinical to early clinical tolerable and pharmacologically active dose ranges for central nervous system active drugs.
Guilherme S Ferreira, Francis M Dijkstra, Désirée H Veening-Griffioen, Wouter P C Boon, Huub Schellekens

Transl Psychiatry· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Toward Responsible Artificial Intelligence in Long-Term Care: A Scoping Review on Practical Approaches.
Dirk R M Lukkien, Henk Herman Nap, Hendrik P Buimer, Alexander Peine, Wouter P C Boon

Gerontologist· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of the new European Union Diagnostics Regulation on the practice of hospital diagnostic laboratories.
Audrey M M Hermans, Marc Maliepaard, Wouter P C Boon, Anna M G Pasmooij

Expert Rev Mol Diagn· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expert perspectives on the introduction of Triple Artemisinin-based Combination Therapies (TACTs) in Southeast Asia: a Delphi study.
Freek de Haan, Wouter P C Boon, Chanaki Amaratunga, Arjen M Dondorp

BMC Public Health· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
To what extent are the antimalarial markets in African countries ready for a transition to triple artemisinin-based combination therapies?
Freek de Haan, Oladimeji Akeem Bolarinwa, Rosemonde Guissou, Fatoumata Tou, Paulina Tindana, Wouter P C Boon

PLoS One· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tradition, not science, is the basis of animal model selection in translational and applied research.
Désirée H Veening-Griffioen, Guilherme S Ferreira, Wouter P C Boon, Christine C Gispen-de Wied, Huub Schellekens

ALTEX· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Market Formation in a Global Health Transition.
Freek de Haan, Ellen H M Moors, Arjen M Dondorp, Wouter P C Boon

Environ Innov Soc Transit· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Ethical, Regulatory and Market related aspects of Deploying Triple Artemisinin-Based Combination Therapies for Malaria treatment in Africa: A study protocol.
Paulina Tindana, Freek de Haan, Olugbenga Ayodeji Mokuolu, Rosemonde Guissou, Oladimeji Akeem Bolarinwa, Wouter P C Boon

Wellcome Open Res· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implementation of artificial intelligence (AI) applications in radiology: hindering and facilitating factors.
Lea Strohm, Charisma Hehakaya, Erik R Ranschaert, Wouter P C Boon, Ellen H M Moors

Eur Radiol· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of drug efficacy in two animal models of type 2 diabetes: A systematic review and meta-analysis.
Guilherme S Ferreira, Désirée H Veening-Griffioen, Wouter P C Boon, Carlijn R Hooijmans, Ellen H M Moors

Eur J Pharmacol· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Levelling the Translational Gap for Animal to Human Efficacy Data.
Guilherme S Ferreira, Désirée H Veening-Griffioen, Wouter P C Boon, Ellen H M Moors, Peter J K van Meer

Animals (Basel)· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A standardised framework to identify optimal animal models for efficacy assessment in drug development.
Guilherme S Ferreira, Désirée H Veening-Griffioen, Wouter P C Boon, Ellen H M Moors, Christine C Gispen-de Wied

PLoS One· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Are some animal models more equal than others? A case study on the translational value of animal models of efficacy for Alzheimer's disease.
Désirée H Veening-Griffioen, Guilherme S Ferreira, Peter J K van Meer, Wouter P C Boon, Christine C Gispen-de Wied

Eur J Pharmacol· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: A standardised framework to identify optimal animal models for efficacy assessment in drug development.
Guilherme S Ferreira, Désirée H Veening-Griffioen, Wouter P C Boon, Ellen H M Moors, Christine C Gispen-de Wied

PLoS One· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring health practitioners' acceptability of a prospective semi-quantitative pfHRP2 device to define severe malaria in the Democratic Republic of Congo.
Freek de Haan, Marie A Onyamboko, Caterina I Fanello, Charles J Woodrow, Yoel Lubell, Wouter P C Boon

Malar J· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An analysis of marketing authorisation applications via the mutual recognition and decentralised procedures in Europe.
Hans C Ebbers, Joris Langedijk, Jacoline C Bouvy, Jarno Hoekman, Wouter P C Boon

Eur J Clin Pharmacol· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of patient advocacy: the case of innovative breast cancer drug reimbursement.
Roel Nahuis, Wouter P C Boon

Sociol Health Illn· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of users in innovation in the pharmaceutical industry.
Ruud E H M Smits, Wouter P C Boon

Drug Discov Today· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis